BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Westport, CT, May 30, 2024 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ:BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of an aggregate of 1,570,683 shares of its common stock at a purchase price of $1.91 per share and concurrent private placement unregistered warrants to purchase up to 1,570,683 shares of common stock at an exercise price of $1.78 per share. The unregistered warrants are immediately exercisable and will expire five years from the date of issuance.
Related news for (BSGM)
- Breaking News: MoBot’s Latest Update as of 09/11/25 02:00 PM
- MoBot’s Stock Market Highlights – 09/11/25 11:00 AM
- BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
- 24/7 Market News Snapshot 14 August, 2025 – BioSig Technologies, Inc. Common Stock (NASDAQ:BSGM)
- Today’s Top Performers: MoBot’s Market Review 07/21/25 05:00 PM